-
Mashup Score: 0Remaining questions regarding the use of frontline CDK4/6 inhibitors and endocrine therapy - 1 year(s) ago
Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, provides expert insights on remaining questions surrounding the use of frontline…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2WHO Global Breast Cancer Initiative (GBCI): improving outcomes in low- and middle-income countries - 1 year(s) ago
Benjamin Anderson, MD, Fred Hutchinson Cancer Center, Seattle, WA, discusses the Global Breast Cancer Initiative Framework, released by the World…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @DocBenGlobal of @fredhutch explains the WHO Global Breast Cancer Initiative (GBCI) framework for addressing improved outomes in low- and middle-income countries Watch: 👉https://t.co/eBxrwUCR8K👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0
Hope S. Rugo, MD, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses challenges in the optimization of management…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @hoperugo of @UCSFCancer talks on optimizing treatment in patients with early-stage HER2-positive breast cancer Watch: 👉https://t.co/nWBtC398t1👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0Strategies to improve the response to immunotherapy in TNBC - 1 year(s) ago
Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands, shares her insights on strategies currently being evaluated to improve the…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Marleen Kok (@lab_kok) of @NKI_nl discusses strategies to improve the response to immunotherapy in TNBC Watch: 👉https://t.co/E3m0gY9FKP👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer - 1 year(s) ago
Icro Meattini, MD, University of Florence, Florence, Italy, discusses the de-escalation of radiation therapy after primary systemic therapy in non-metastatic…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @Icro_Meattini of @UNI_FIRENZE talks on de-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer Watch: 👉https://t.co/YbqyPzuOec👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0Important considerations in the management of HR+, HER2-negative early breast cancer - 1 year(s) ago
Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, provides insights and expertise on the management of HR+, HER2-negative early…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @stolaney1 of @DanaFarberNews discusses important considerations in the management of HR+, HER2-negative early breast cancer Watch: 👉https://t.co/MU1fFEQ5zQ👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0Axillary dissection vs radiation for residual nodal disease after neoadjuvant systemic therapy - 1 year(s) ago
Orit Kaidar-Person, MD, Sheba Medical Center, Ramat Gan, Israel, discusses a debate held during the St. Gallen International Breast Cancer…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @KaidarOrit of @sheba_medical talks on axillary dissection versus axillary radiation for residual nodal disease after neoadjuvant systemic therapy Watch: 👉https://t.co/7WHwtDNjAv👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0VJOncology – The video journal of oncology - 1 year(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
It’s been one week since #SGBCC2023 and we’re still posting exclusive content, so please take a look at https://t.co/ys1d8pDAKO for more! @sg_bcc #BreastCancer #BCsm https://t.co/4V5Wmx5HVW
-
-
Mashup Score: 1De-escalation of axillary radiotherapy in early breast cancer - 1 year(s) ago
Icro Meattini, MD, University of Florence, Florence, Italy, discusses de-escalation of axillary radiotherapy, highlighting lower-risk patients that receive upfront surgery,…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @Icro_Meattini of @UNI_FIRENZE talks on de-escalation of axillary radiotherapy in early breast cancer Watch: 👉https://t.co/LI7fkpXUFf👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0Multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer - 1 year(s) ago
Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands, discusses spatial analysis in breast cancer to predict outcomes to immunotherapy,…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Marleen Kok (@lab_kok) of @NKI_nl talks on multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer Watch: 👉https://t.co/twaG0AHStt👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
🎥 @stolaney1 of @DanaFarberNews talks on remaining questions regarding the use of frontline CDK4/6 inhibitors and endocrine therapy Watch: 👉https://t.co/hDLAISGCff👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer